Speaker Biographies

2020 Conference Programs

September 16 - 17

Target Identification and Validation – Part 1

RNA as a Drug Target

PROTACs and Targeted Protein Degradation – Part 1

Lead and Candidate Selection for Therapeutic Proteins

Antibodies Against Membrane Protein Targets – Part 1

Small G Proteins

Immunology and Oncology

Targeting NASH

September 17 - 18

Target Identification and Validation – Part 2

Lead Generation Strategies

PROTACs and Targeted Protein Degradation – Part 2

Modality Selection for Next-Gen Biotherapeutics

Antibodies Against Membrane Protein Targets – Part 2

Kinase Inhibitor Discovery

GPCR-Based Drug Discovery

Targeting Fibrosis